首页> 外国专利> RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF PROVASOPRESSIN OR FRAGMENTS AND PARTIAL PEPTIDES THEREOF, IN PARTICULAR COPEPTIN OR NEUROPHYSIN II

RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF PROVASOPRESSIN OR FRAGMENTS AND PARTIAL PEPTIDES THEREOF, IN PARTICULAR COPEPTIN OR NEUROPHYSIN II

机译:血管紧张素Ⅱ或其片段和部分肽对特定冠蛋白或神经PHYS的急性冠状动脉综合征的危险分层II

摘要

PROBLEM TO BE SOLVED: To provide a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in-vitro diagnosis.;SOLUTION: Provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, which has high sensitivity and specificity for the diagnosis of acute coronary syndrome is determined by an in-vitro diagnosis.;COPYRIGHT: (C)2013,JPO&INPIT
机译:解决的问题:提供一种对急性冠状动脉综合征(ACS),特别是急性心肌梗塞(AMI)和心绞痛(AP)进行危险分层的方法,其中血管加压素(proAVP)或其片段和部分肽,特别是肽素解决方案:通过对急性冠脉综合征的诊断具有高度敏感性和特异性的前加压素(proAVP)或其片段和部分肽,特别是肽素或神经素II,可以通过体外诊断来确定。体外诊断;版权所有:(C)2013,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号